Anteilseigner
BlackRock Fund Advisors (5,97 %) The Vanguard Group, Inc. (4,94 %) MPM BioImpact, Inc (2,81 %) SSgA Funds Management, Inc. (2,17 %) Geode Capital Management LLC (2,05 %) Rosalind Advisors, Inc. (1,90 %) Millennium Management LLC (1,14 %) CenterBook Partners LP (1,04 %) TIAA-CREF Investment Management LLC (0,83 %) Northern Trust Investments, Inc.(Investment Management) (0,78 %) AQR Capital Management LLC (0,77 %) Redmile Group LLC (0,71 %) Renaissance Technologies LLC (0,68 %) Morgan Stanley & Co. LLC (0,66 %) Apo Asset Management GmbH (0,65 %) Columbia Management Investment Advisers LLC (0,64 %) Steven Prestrelski (0,49 %)
Kontakt
Xeris Biopharma Holdings Inc.